Published

Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Pharmacological reports: PR
Date: 2023-12-01
Source: PubMed
DOI: 10.1007/s43440-023-00547-4
PubMed: 37932583

Authors

Chruścicka-Smaga B Machaczka A Szewczyk B Pilc A

Watch author

Derived topics and classifications

psilocybin Depression Neuroplasticity Mechanism of Action Receptor Pharmacology Review Article Drug Interactions Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.2023-12-01

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01